Cancer genetics

JAMA

Volumn 277, Issue 23, 1997, Pages 1880-1881

  Yoshida, Teruhiko ^a   Terada, Masaaki ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; CHROMOSOME 3P; GENE ASSIGNMENT; GENE LOCATION; HUMAN; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; APOPTOSIS; ARTICLE; GENE THERAPY; GENETICS; NEOPLASM; ONCOGENE; ONCOLOGY;

ACID ANHYDRIDE HYDROLASE; DNA BINDING PROTEIN; FRAGILE HISTIDINE TRIAD PROTEIN; PROTEIN; SMAD4 PROTEIN; SMAD4 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR PROTEIN;

ACID ANHYDRIDE HYDROLASES; APOPTOSIS; DNA-BINDING PROTEINS; GENE THERAPY; GENES, TUMOR SUPPRESSOR; HUMANS; MEDICAL ONCOLOGY; NEOPLASM PROTEINS; NEOPLASMS; ONCOGENES; PROTEINS; SMAD4 PROTEIN; TRANS-ACTIVATORS;

EID: 0031577072     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.23.1880     Document Type: Short Survey

References (18)

1. Hahn SA, Schutte M, Hoque AT, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 1996;271:350-353.
2. Schutte M, Hruban RH, Hedrick L, et al. DPC4 gene in various tumor types. Cancer Res. 1996;56:2527-2530.
3. Ohta M, Inoue H, Cotticelli MG, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell. 1996;84:587-597.
4. Barnes LD, Garrison PN, Siprashvili Z, et al. FHIT, a putative tumor suppressor in humans, is a dinucleoside 5′,5′ -P1,P3-triphosphate hydrolase. Biochemistry. 1996; 35:11529-11535.
5. Sozzi G, Veronese ML, Negrini M, et al. The FHIT gene 3p14.2 is abnormal in lung cancer. Cell. 1996;85:17-26.
6. Negrini M, Monaco C, Vorechovsky I, et al. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res. 1996;56:3173-3179.
7. Goffeau A, Barrell BG, Bussey H, et al. Life with 6000 genes. Science. 1996;274: 546-567.
8. Dietrich WF, Miller J, Steen R, et al. A comprehensive genetic map of the mouse genome. Nature. 1996;380:149-152.
9. Dib C, Faure S, Fizames C, et al. A comprehensive genetic map of the human genome based on 5264 microsatellites. Nature. 1996;380:152-154.
10. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science. 1996;272:1023-1026.
11. Matsumine A, Ogai A, Senda T, et al. Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein. Science. 1996;272:1020-1023.
12. Naik P, Karrim J, Hanahan D. The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev. 1996;10:2105-2116.
13. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 1996;85:803-815.
14. Muzio M, Chinnaiyan AM, Kischkel FC, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing sig-naling complex. Cell. 1996;85:817-827.
15. Hahne M, Rimoldi D. Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science. 1996;274:1363-1366.
16. Chen XQ, Stroun M, Magnenat JL, et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med. 1996;2:1033-1035.
17. Nawroz H, Koch W, Anker P, Stroun M, Sidransky D. Mierosatellite alterations in serum DNA of head and neck cancer patients. Nat Med. 1996;2:1035-1037.
18. Roth JA, Nguyen D, Lawrence DD, et al. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med. 1996;2:985-991.